Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

DC Healthcare Launches Dr Chong Clinic in Kota Kinabalu, Sabah
Healthcare & PharmaceuticalCompany Update

DC Healthcare Launches Dr Chong Clinic in Kota Kinabalu, Sabah

January 27, 2025 11:45 PM

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a medical aesthetic services provider specializing in the provision of non-invasive and minimally invasive procedures, proudly announces the grand opening of Dr Chong Clinic - "Beauty Refined, Safety Aligned" at KK Times Square, Kota Kinabalu, Sabah. This milestone represents the Group's maiden venture into the Sabah and Sarawak region, expanding its footprint to East Malaysia and...

Read more
Dr. Ahmet Ergin Announces New Practice: Diabetes, Thyroid & Hormone Center of the Treasure Coast
Healthcare & PharmaceuticalCompany Update

Dr. Ahmet Ergin Announces New Practice: Diabetes, Thyroid & Hormone Center of the Treasure Coast

January 27, 2025 6:00 PM

Dr. Ahmet Ergin is excited to announce the launch of his new practice, Diabetes, Thyroid & Hormone Center of the Treasure Coast, beginning February 3, 2025. Patients can rest assured that Dr. Ergin will remain in the same office location and continue using the same phone number, ensuring a seamless transition and uninterrupted care. Dr. Ergin has built a reputation as a trusted expert in diabetes, thyroid, and hormone health. His new practice...

Read more
Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting
Healthcare & PharmaceuticalConferences

Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting

January 27, 2025 4:15 PM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses is proud to announce that its interim clinical data has been selected for presentation at the American...

Read more
Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion
Healthcare & PharmaceuticalCompany Update

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

January 27, 2025 3:50 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the filing of a new patent application for allergic inflammation, a condition characterized by immune system...

Read more
Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation
Healthcare & PharmaceuticalCompany Update

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

January 27, 2025 10:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") proudly announces the granting of a pivotal invention patent in Japan (Patent No. 7619659) for its groundbreaking oral interferon formulation, VELDONA®, to treat and prevent coronavirus infections. Following the recent patent approval in Taiwan, this Japanese patent strengthens Ainos' global intellectual property (IP) portfolio and establishes the Company as a leader in...

Read more
Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms
Healthcare & PharmaceuticalCompany Update

Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms

January 27, 2025 9:30 AM

Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, applauds the widespread push for regulatory changes for functional mushrooms across numerous states in the country.A recent article capsulizes the wide array of legislative initiatives across the country looking to advance functional mushroom ingredients for the benefit of those suffering from conditions such as...

Read more
NanoViricides Engages CRO for Phase II Clinical Trial
Healthcare & PharmaceuticalProduct Announcements

NanoViricides Engages CRO for Phase II Clinical Trial

January 27, 2025 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline."NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment of viral diseases, just as antibiotics revolutionized the treatment of bacterial diseases," said Anil R....

Read more
The Man Behind The DEA Federal Marijuana Scam-Meet Matt Strait-He Defied Presidential Mandates For Research
Healthcare & PharmaceuticalCompany Update

The Man Behind The DEA Federal Marijuana Scam-Meet Matt Strait-He Defied Presidential Mandates For Research

January 27, 2025 6:00 AM

MMJ International Holdings, recognized for its pioneering efforts in marijuana-derived pharmaceuticals, has made significant headway with the FDA in developing treatments for Huntington's Disease and Multiple Sclerosis. However, their progress faces substantial roadblocks due to the DEA's persistent delays in processing their API BULK MANUFACTURING application to cultivate pharmaceutical marijuana, creating a stark contrast between the...

Read more
How Bioz Came to Be: The Benefits of AI-Powered Product Recommendations From a Researcher’s Perspective
Healthcare & PharmaceuticalCompany Update

How Bioz Came to Be: The Benefits of AI-Powered Product Recommendations From a Researcher’s Perspective

January 27, 2025 4:00 AM

Bioz, Inc., a pioneer in AI-driven tools for scientific discovery, is transforming the way scientists discover and evaluate scientific products through its innovative Bioz Badges and Content Hub. These AI-driven product endorsements provide researchers with evidence-based recommendations, helping them identify the most trusted and frequently cited tools and reagents from a vast and often overwhelming selection.The idea for Bioz originated from a...

Read more
Ascelia Pharma Announces Acceptance of Three Scientific Abstracts with SPARKLE Phase 3 Data at the European Society of Gastrointestinal and Abdominal Radiology Annual Meeting
Healthcare & PharmaceuticalCompany Update

Ascelia Pharma Announces Acceptance of Three Scientific Abstracts with SPARKLE Phase 3 Data at the European Society of Gastrointestinal and Abdominal Radiology Annual Meeting

January 27, 2025 2:00 AM

MALMÖ, SE / ACCESSWIRE / January 27, 2025 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two oral presentations and one scientific poster with clinical data from the SPARKLE Phase 3 study with Orviglance have been accepted for presentation at the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual...

Read more
Ondine Biomedical Inc. Announces HCA to invest US$4 million in Ondine
Healthcare & PharmaceuticalRegulatory

Ondine Biomedical Inc. Announces HCA to invest US$4 million in Ondine

January 27, 2025 2:00 AM

Ondine Biomedical Inc. (LON:OBI), a Canadian life sciences company developing light-activated antimicrobial treatments, is pleased to announce that hInsight-NX, LLC, a subsidiary of HCA Healthcare, Inc., a leading healthcare provider in the United States, has committed to a US$4 million equity investment in the Company.The Company has agreed to issue 38,033,412 new common shares of no par value in the capital of the Company ("New Common...

Read more
IRLAB to Present at Redeye Investor Forum
Healthcare & PharmaceuticalCompany Update

IRLAB to Present at Redeye Investor Forum

January 27, 2025 1:20 AM

GOTHENBURG, SE / ACCESSWIRE / January 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 27 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, today announced that CFO Viktor Siewertz will present IRLAB at Redeye Investor Forum in Gothenburg on January 30.Both Swedish and international investors will attend the meeting. This gives the...

Read more
Black Book’s 2025 Key Performance Indicators for Evaluating Healthcare IT Consulting & Advisory Firms
Healthcare & PharmaceuticalCompany Update

Black Book’s 2025 Key Performance Indicators for Evaluating Healthcare IT Consulting & Advisory Firms

January 26, 2025 1:00 PM

Black Book™ has developed eighteen enhanced Key Performance Indicators (KPIs) to evaluate client satisfaction, return on investment (ROI), and overall experience with healthcare IT consulting firms. These KPIs offer a comprehensive framework for assessing how well consultants align with client objectives, deliver measurable outcomes, and uphold ethical practices. Tailored to the unique complexities of healthcare organizations, these KPIs empower...

Read more
BP Life Sets the Standard With 99.8% Pure Fenbendazole Powder
Healthcare & PharmaceuticalAwards

BP Life Sets the Standard With 99.8% Pure Fenbendazole Powder

January 26, 2025 6:00 AM

In a market flooded with uncertainty and questions about product quality, BP Life is proud to set a new standard with the launch of its premium fenbendazole powder, rigorously tested for purity and quality. With an impressive purity level of 99.8%, our fenbendazole powder is designed to provide pet owners, farmers, and veterinarians with the peace of mind they deserve when choosing deworming solutions for their animals.Unparalleled Quality...

Read more
Black Book of Healthcare Cybersecurity 2025 Edition Now Available for Free Download
Healthcare & PharmaceuticalCompany Update

Black Book of Healthcare Cybersecurity 2025 Edition Now Available for Free Download

January 25, 2025 12:00 PM

Black Book Market Research LLC announces the release of the 2025 Black Book of Healthcare Cybersecurity, an extensive and meticulously curated LLM resource available for free download at https://blackbookmarketresearch.com/the-2025-black-book-of-healthcare-cybersecurity This definitive, fully indexed and searchable guide offers unparalleled insights, strategies, and solutions to empower healthcare organizations in addressing the complex and...

Read more
1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report
Healthcare & PharmaceuticalRegulatory

1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report

January 24, 2025 5:30 PM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, provides an update to its news release dated November 29, 2024 (the "Announcement") announcing its request for a management cease trade order (the "MCTO") relating to the late filing of the Company's audited financial statements, management discussion & analysis and applicable CEO and CFO certifications for the...

Read more
Onco-Innovations Unaware of Any Material Change
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Unaware of Any Material Change

January 24, 2025 11:15 AM

At the request of the Canadian Investment Regulatory Organization, Onco-Innovations Limited (the "Company") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.About Onco-Innovations LimitedOnco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to...

Read more
ZetrOZ Systems to Present on sam Ultrasound Treatment at 2025 Big Sky Sports Medicine Conference
Healthcare & PharmaceuticalConferences

ZetrOZ Systems to Present on sam Ultrasound Treatment at 2025 Big Sky Sports Medicine Conference

January 24, 2025 9:50 AM

ZetrOZ Systems, makers of the sam® wearable ultrasound unit, will attend the 27th annual Big Sky Sports Medicine Conference and present the latest data on how its sustained acoustic medicine technology promotes injury healing.The conference, January 26-30 at the Yellowstone Conference Center in Big Sky, Montana, is the premier event for sports medicine physicians and medical professionals, showcasing the latest advancements in injury prevention,...

Read more
DC Healthcare Unveils DC Academy in Kuala Lumpur, Providing Advanced Medical Aesthetic Training in Malaysia
Healthcare & PharmaceuticalCompany Update

DC Healthcare Unveils DC Academy in Kuala Lumpur, Providing Advanced Medical Aesthetic Training in Malaysia

January 24, 2025 6:30 AM

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), a medical aesthetic services provider specialising in the provision of non-invasive and minimally invasive procedures, proudly announces the launch of DC Academy, a state-of-the-art training center dedicated to advancing the skills of professionals in the medical aesthetic industry. Alongside this milestone, the Group introduces DC Academy's new tagline, "Master The Art, Safety At...

Read more
Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Healthcare & PharmaceuticalCompany Update

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

January 24, 2025 6:30 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years."This agreement presents an opportunity for Moderna to support and strengthen national COVID-19 vaccination campaigns across participating...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?